Ladenburg Thalmann Financial Services’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIB
SBIA
SW
Ladenburg Thalmann Financial Services's BIB Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services increased its ProShares Ultra NASDAQ Biotechnology (BIB) stake by 500% in Q4 2019, buying an estimated $26.7K and bringing the position to 600 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3725.
Ladenburg Thalmann Financial Services first reported a position in BIB in Q1 2015 and has held it in 20 quarters since. The position peaked at $81K in Q2 2015. 26 funds tracked by Wall St. Rank hold BIB as of Q4 2019.
- Ladenburg Thalmann Financial Services held 600 shares of ProShares Ultra NASDAQ Biotechnology worth $37K as of Q4 2019.
- Ladenburg Thalmann Financial Services bought 500 ProShares Ultra NASDAQ Biotechnology shares in Q4 2019, an estimated $26.7K.
- ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3725 holding.
- Ladenburg Thalmann Financial Services first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2015 and has held it in 20 quarters since.
- Ladenburg Thalmann Financial Services's ProShares Ultra NASDAQ Biotechnology position peaked at $81K in Q2 2015.
- 26 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.